Antioxidant and Cytotoxicity Potential of Piperine and Sorafenib combination in human MDA-MB-231 Breast Cancer cells
Last updated: 24 Dec 2024
10.21608/blj.2021.200558
Piperine, Sorafenib, Lipid peroxidation, antioxidants, breast cancer
Hany
Mohany
Department of Chemistry, Faculty of Science, Kafr el sheikh University.
Mohammad A.
Mahmoud
Department of Chemistry, Faculty of Science, Kafr el sheikh University.
Ashraf A.
El-Shehawy
Department of Chemistry, Faculty of Science, Kafr el sheikh University.
Mohamed
Gaber
Chemistry Department, Faculty of Science, Tanta University
Alaa
Elmetwalli
Department of Clinical Trial Research Unit and Drug Discovery, Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt.
dr.prof2011@gmail.com
0000-0001-5372-4297
Afrah F.
Salama
Biochemistry Section, Chemistry Department, Faculty of Science, Tanta University.
Tarek
El Sewedy
Department of Applied Medical Chemistry, Medical Research Institute, Alexandria University
17
1
26011
2021-12-01
2021-09-14
2021-12-01
108
116
1687-4773
2974-4725
https://blj.journals.ekb.eg/article_200558.html
https://blj.journals.ekb.eg/service?article_code=200558
10
Original Article
988
Journal
Biochemistry Letters
https://blj.journals.ekb.eg/
Antioxidant and Cytotoxicity Potential of Piperine and Sorafenib combination in human MDA-MB-231 Breast Cancer cells
Details
Type
Article
Created At
22 Jan 2023